Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
NDUFS1 (NADH dehydrogenase (ubiquinone) Fe-S protein 1) plays a key role in the maintenance of mitochondrial function as the largest subunit of mitochondrial complex I. In recent years, studies have found that the expression of NDUFS1 is decreased in tumor cells, which may be closely related to tumor development.
Complex I, i.e. NADH dehydrogenase, is the entry point for oxidative phosphorylation. By changing the mitochondrial membrane potential, NADH is converted to NAD+, producing ATP and by-product ROS. It is the largest complex in the electron transport chain of mitochondria and consists of a total of 45 subunits, 14 of which are core subunits. Seven of the 14 core subunits are encoded by mitochondrial DNA (mtDNA) and seven by nuclear DNA (nDNA). The core subunits encoded by nuclear DNA (nDNA) are: NDUFS1, which belongs to the NADH dehydrogenase module. NDUFV1 and NDUFV2; and NDUFS2, NDUFS3, NDUFS7, and NDUFS8 belonging to the oxidase module. NDUFS1 is the largest subunit of complex I (and thus considered to be a marker for complex I) and has NADH dehydrogenase and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain.
Figure 1. MDM2 integrates cellular respiration and apoptotic signaling through NDUFS1 and the mitochondrial network. (Elkholi, R., et al. 2019)
NDUFS1 Mutation
In human fibroblasts with NDUFS1 subunit mutations, a decrease in mitochondrial membrane potential and an increase in mitochondrial DNA-encoded respiratory complex subunit expression (compensatory response) occurred. The level of NDUFS1 and serum tumor necrosis factor (TNF)-α in renal cell carcinoma patients increased with the increase of cancer stage. It was analyzed that TNF-α may be involved in NDUFS 1 gene silencing, resulting in decreased NDUFS1 expression. NDUFS1 gene expression is regulated by NUBPL (nucleotide binding protein), and knockdown of NDUBPL results in decreased expression of NDUFS 1 accompanied by a decrease in complex I activity. The above experimental phenomena indicate that NDUFS1, as a core subunit encoded by the nuclear gene in mitochondrial complex I, may cause loss and abnormal expression of related mitochondria-associated subunits if its gene is mutated or abnormal during transcription and translation. This causes mitochondrial dysfunction, leading to diseases such as cancer.
When external physical, chemical, biological and other factors oxidatively stimulate mitochondria in the body, glutathionization is inactivated in the core subunit NDUFS1 of mitochondrial complex I. This causes the electronic respiratory transfer chain to be blocked, and the body produces a large amount of ROS, which in turn causes a series of corresponding changes.
The Regulation Mechanism of NDUFS1 on Tumor Progression
When mitochondrial function is normal, ROS in the body are maintained in a balanced state and participate in activities such as redox regulation and biological information transmission in the body. When the body is in oxidative stress, the NDUFS1 subunit is inactivated, resulting in an obstacle to the electronic respiratory transmission chain and a large amount of reactive oxygen species. However, the regulation of tumors by reactive oxygen species shows a dual effect, so it can be considered that the inactivation of NDUFS1 has a double effect on tumor development.
After conducting experiments on the expression of NDUFS1 in lung cancer and renal cancer patients, the results of the analysis of patient-related data revealed that NDUFS1 can be used as a diagnostic marker for renal cancer, as well as pathological staging and grading of lung cancer and renal cancer. There is a significant correlation between lymph node and distant metastasis and patient survival. The expression of NDUFS1 is the lower, and the stage of cancer patients is the higher. It has been found that NDUFS1 shows a strong independent prognostic effect.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.